{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:15:48Z","timestamp":1788794148812,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300681"],"award-info":[{"award-number":["82300681"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["2023JJ40856"],"award-info":[{"award-number":["2023JJ40856"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL165129"],"award-info":[{"award-number":["R01HL165129"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["971273"],"award-info":[{"award-number":["971273"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["23DIVSUP1071039"],"award-info":[{"award-number":["23DIVSUP1071039"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jlr.2024.100515","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:47:45Z","timestamp":1706834865000},"page":"100515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Geranylgeranyl isoprenoids and hepatic Rap1a regulate basal and statin-induced expression of PCSK9"],"prefix":"10.1016","volume":"65","author":[{"given":"Yating","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-5832","authenticated-orcid":false,"given":"Brea","family":"Tinsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Spolitu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Zadroga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2334-4685","authenticated-orcid":false,"given":"Heena","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amesh K.","family":"Sarecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2710-7057","authenticated-orcid":false,"given":"Lale","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2024.100515_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jlr.2024.100515_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tibs.2006.12.008","article-title":"Molecular biology of PCSK9: its role in LDL metabolism","volume":"32","author":"Horton","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jlr.2024.100515_bib3","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/CIRCRESAHA.118.311227","article-title":"PCSK9: from basic science discoveries to clinical trials","volume":"122","author":"Shapiro","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2024.100515_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1194\/jlr.M078360","article-title":"PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction","volume":"59","author":"Sun","year":"2018","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100515_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11883-018-0718-x","article-title":"Pleiotropic anti-atherosclerotic effects of PCSK9 InhibitorsFrom molecular biology to clinical Translation","volume":"20","author":"Karagiannis","year":"2018","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.jlr.2024.100515_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jacl.2017.10.001","article-title":"Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk","volume":"12","author":"Arsenault","year":"2018","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2024.100515_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/ehjcvp\/pvz022","article-title":"PCSK9 and inflammation: a review of experimental and clinical evidence","volume":"5","author":"Momtazi-Borojeni","year":"2019","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.jlr.2024.100515_bib8","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0735-1097(20)32739-X","article-title":"PCSK9 inhibition and aortic stenosis in the FOURIER TRIAL","volume":"75","author":"Bergmark","year":"2020","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2024.100515_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40273-015-0355-y","article-title":"PCSK9 inhibitors: a Technology Worth Paying for?","volume":"34","author":"Weintraub","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jlr.2024.100515_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s40256-021-00477-7","article-title":"A\u00a0critical review of the efficacy and safety of Inclisiran","volume":"21","author":"Hardy","year":"2021","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.jlr.2024.100515_bib11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2024.100515_bib12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2024.100515_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1741826711400545","article-title":"Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada","volume":"19","author":"Gitt","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.jlr.2024.100515_bib14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacl.2015.05.003","article-title":"Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: national Health and Nutrition Examination Survey 2009-2010","volume":"9","author":"Wong","year":"2015","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2024.100515_bib15","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/eurheartj\/ehw046","article-title":"Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2024.100515_bib16","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1016\/S1520-765X(01)90108-7","article-title":"Cholesterol absorption inhibition: filling an unmet need in lipid-lowering management","volume":"3","author":"Leitersdorf","year":"2001","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.jlr.2024.100515_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.117.002043","article-title":"Characterization of statin low-density lipoprotein cholesterol dose-response using electronic health records in a large population-based cohort","volume":"11","author":"Oni-Orisan","year":"2018","journal-title":"Circ. Genom. Precis. Med."},{"key":"10.1016\/j.jlr.2024.100515_bib18","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.ATV.0000134621.14315.43","article-title":"Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia","volume":"24","author":"Dubuc","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2024.100515_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1373\/clinchem.2011.172932","article-title":"Rosuvastatin, proprotein convertase subtilisin\/kexin type 9 concentrations, and LDL cholesterol response: the JUPITER trial","volume":"58","author":"Awan","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jlr.2024.100515_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060095","article-title":"Evidence from a randomized trial that simvastatin, but not ezetimibe, upregulates circulating PCSK9 levels","volume":"8","author":"Berthold","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100515_bib21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.5551\/jat.RV17012","article-title":"Lipid lowering therapy and circulating PCSK9 concentration","volume":"24","author":"Nozue","year":"2017","journal-title":"J.\u00a0Atheroscler. Thromb."},{"key":"10.1016\/j.jlr.2024.100515_bib22","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1194\/jlr.M008144","article-title":"High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol","volume":"51","author":"Welder","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100515_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173114","article-title":"Statins and PCSK9 inhibitors: a new lipid-lowering therapy","volume":"878","author":"Gallego-Colon","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jlr.2024.100515_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40256-015-0119-2","article-title":"Impact of ezetimibe alone or in addition to a statin on plasma PCSK9 concentrations in patients with type 2 diabetes and hypercholesterolemia: a Pilot study","volume":"15","author":"Miyoshi","year":"2015","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.jlr.2024.100515_bib25","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1194\/jlr.M003566","article-title":"Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters","volume":"51","author":"Dong","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100515_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1194\/jlr.M700443-JLR200","article-title":"Sterol-dependent regulation of proprotein convertase subtilisin\/kexin type 9 expression by sterol-regulatory element binding protein-2","volume":"49","author":"Jeong","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100515_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1874467209666160112123746","article-title":"Mevalonate Cascade and its regulation in cholesterol metabolism in different tissues in Health and disease","volume":"10","author":"Hashemi","year":"2017","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.jlr.2024.100515_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.abb.2010.09.028","article-title":"Enzymes of the mevalonate pathway of isoprenoid biosynthesis","volume":"505","author":"Miziorko","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jlr.2024.100515_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm.2015.11","article-title":"Protein prenylation: unique fats make their mark on biology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jlr.2024.100515_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.tcb.2011.07.001","article-title":"Regulating Rap small G-proteins in time and space","volume":"21","author":"Gloerich","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jlr.2024.100515_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4161\/sgtp.2.2.15735","article-title":"Isoform-specific differences between Rap1A and Rap1B GTPases in the formation of endothelial cell junctions","volume":"2","author":"Wittchen","year":"2011","journal-title":"Small GTPases"},{"key":"10.1016\/j.jlr.2024.100515_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0092-8674(89)90985-9","article-title":"A\u00a0ras-related gene with transformation suppressor activity","volume":"56","author":"Kitayama","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.jlr.2024.100515_bib33","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s11883-023-01162-7","article-title":"Rap1 in the Context of PCSK9, atherosclerosis, and diabetes","volume":"25","author":"Agarwal","year":"2023","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.jlr.2024.100515_bib34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/24884","article-title":"Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP","volume":"396","author":"de Rooij","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2024.100515_bib35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2007.05.018","article-title":"GEFs and GAPs: critical elements in the control of small G proteins","volume":"129","author":"Bos","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jlr.2024.100515_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/CIRCRESAHA.118.313648","article-title":"Hepatic glucagon signaling regulates PCSK9 and low-density lipoprotein cholesterol","volume":"124","author":"Spolitu","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2024.100515_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111259","article-title":"Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia","volume":"40","author":"Wang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jlr.2024.100515_bib38","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2020.03.010","article-title":"Cholesterol Stabilizes TAZ in hepatocytes to promote experimental non-alcoholic Steatohepatitis","volume":"31","author":"Wang","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2024.100515_bib39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12875","article-title":"Selection and evaluation of clinically relevant AAV variants in a xenograft liver model","volume":"506","author":"Lisowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2024.100515_bib40","doi-asserted-by":"crossref","first-page":"11675","DOI":"10.1074\/jbc.M412595200","article-title":"Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function","volume":"280","author":"Wittchen","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100515_bib41","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1016\/j.jmb.2016.10.016","article-title":"Differences in the Phosphorylation-dependent regulation of prenylation of Rap1A and Rap1B","volume":"428","author":"Wilson","year":"2016","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jlr.2024.100515_bib42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCRESAHA.117.311361","article-title":"Novel reversible model of atherosclerosis and Regression using oligonucleotide regulation of the LDL receptor","volume":"122","author":"Basu","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2024.100515_bib43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2012.03.002","article-title":"Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity","volume":"15","author":"Ozcan","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2024.100515_bib44","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1021\/jm9902786","article-title":"Novel farnesol and geranylgeraniol analogues: a potential new class of anticancer agents directed against protein prenylation","volume":"42","author":"Gibbs","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jlr.2024.100515_bib45","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1073\/pnas.0501652102","article-title":"Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9","volume":"102","author":"Rashid","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100515_bib46","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1074\/jbc.M113.527192","article-title":"The chaperone protein SmgGDS interacts with small GTPases entering the prenylation pathway by recognizing the last amino acid in the CAAX motif","volume":"289","author":"Schuld","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100515_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1021\/cb500791f","article-title":"Protein prenylation: enzymes, therapeutics, and biotechnology applications","volume":"10","author":"Palsuledesai","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jlr.2024.100515_bib48","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11427-015-4836-1","article-title":"Protein prenylation and human diseases: a balance of protein farnesylation and geranylgeranylation","volume":"58","author":"Xu","year":"2015","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jlr.2024.100515_bib49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.pharmtox.010909.105714","article-title":"Epac: defining a new mechanism for cAMP action","volume":"50","author":"Gloerich","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jlr.2024.100515_bib50","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1002\/jcp.26487","article-title":"Regulation of RhoA GTPase and various transcription factors in the RhoA pathway","volume":"233","author":"Kim","year":"2018","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.jlr.2024.100515_bib51","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1038\/cddis.2013.103","article-title":"Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases","volume":"4","author":"Zhu","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jlr.2024.100515_bib52","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s00417-021-05328-4","article-title":"Pitavastatin stimulates retinal angiogenesis via HMG-CoA reductase-independent activation of RhoA-mediated pathways and focal adhesion","volume":"259","author":"Li","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jlr.2024.100515_bib53","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1038\/s41467-019-11606-x","article-title":"Protein prenylation restrains innate immunity by inhibiting Rac1 effector interactions","volume":"10","author":"Akula","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2024.100515_bib54","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1172\/JCI43758","article-title":"Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice","volume":"121","author":"Khan","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2024.100515_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003058","article-title":"RHOA is a modulator of the cholesterol-lowering effects of statin","volume":"8","author":"Medina","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jlr.2024.100515_bib56","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1128\/MCB.01453-14","article-title":"Rap1 Spatially controls ArhGAP29 to inhibit Rho signaling during endothelial barrier regulation","volume":"35","author":"Post","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jlr.2024.100515_bib57","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1073\/pnas.1306595110","article-title":"Rasip1 mediates Rap1 regulation of Rho in endothelial barrier function through ArhGAP29","volume":"110","author":"Post","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100515_bib58","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1194\/jlr.M028563","article-title":"Molecular characterization of proprotein convertase subtilisin\/kexin type 9-mediated degradation of the LDLR","volume":"53","author":"Wang","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100515_bib59","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1194\/jlr.M044156","article-title":"Internalized PCSK9 dissociates from recycling LDL receptors in PCSK9-resistant SV-589 fibroblasts","volume":"55","author":"Nguyen","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100515_bib60","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12931-019-1260-2","article-title":"Exchange protein directly activated by cAMP (Epac) protects against airway inflammation and airway remodeling in asthmatic mice","volume":"20","author":"Chen","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.jlr.2024.100515_bib61","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2010040423","article-title":"Epac-Rap signaling reduces cellular stress and ischemia-induced kidney failure","volume":"22","author":"Stokman","year":"2011","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jlr.2024.100515_bib62","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2016.14568","article-title":"Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis","volume":"316","author":"Lotta","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jlr.2024.100515_bib63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2213-8587(16)30396-5","article-title":"PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study","volume":"5","author":"Schmidt","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jlr.2024.100515_bib64","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","article-title":"Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes","volume":"375","author":"Ference","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2024.100515_bib65","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1080\/1061186X.2022.2092622","article-title":"Molecular and cellular biology of PCSK9: impact on glucose homeostasis","volume":"30","author":"Tcheoubi","year":"2022","journal-title":"J.\u00a0Drug Target."},{"key":"10.1016\/j.jlr.2024.100515_bib66","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/eurheartj\/ehw292","article-title":"No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies","volume":"37","author":"Colhoun","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2024.100515_bib67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/dom.12788","article-title":"Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome","volume":"19","author":"Blom","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.jlr.2024.100515_bib68","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/dc17-1464","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitors and incident type 2 diabetes: a systematic review and meta-analysis with over 96,000 patient-Years","volume":"41","author":"de Carvalho","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jlr.2024.100515_bib69","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00210-017-1343-x","article-title":"Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage","volume":"390","author":"Abdali","year":"2017","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:34:31Z","timestamp":1758306871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227524000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0022227524000208"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100515","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.23.563509","asserted-by":"object"}]},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geranylgeranyl isoprenoids and hepatic Rap1a regulate basal and statin-induced expression of PCSK9","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100515"}}